These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21524267)

  • 1. Pharmacological treatments of opiate dependence.
    Benyamina A; Reynaud M; Blecha L; Karila L
    Curr Pharm Des; 2011; 17(14):1384-8. PubMed ID: 21524267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Substitution therapy with diamorphine].
    Roy M; Bleich S; Hillemacher T
    Fortschr Neurol Psychiatr; 2016 Mar; 84(3):164-76; quiz 177-8. PubMed ID: 27029045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving recruitment to pharmacological trials for illicit opioid use: findings from a qualitative focus group study.
    Neale J; Tompkins CNE; McDonald R; Strang J
    Addiction; 2018 Jun; 113(6):1066-1076. PubMed ID: 29356208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heroin anticraving medications: a systematic review.
    Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
    Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine/naloxone maintenance treatment.
    González-Saiz F; Lozano Rojas O; Trujols J; Alcaraz S; Siñol N; Pérez de Los Cobos J;
    Drug Alcohol Depend; 2018 Feb; 183():127-133. PubMed ID: 29247974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
    Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
    Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
    Maas J; Barton G; Maskrey V; Pinto H; Holland R
    Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary on Holland et al. (2014): Opioid maintenance treatment--how much supervision is helpful?
    Koller G
    Addiction; 2014 Apr; 109(4):608-9. PubMed ID: 24605959
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving care for hospitalized, opioid-dependent patients: a promising start.
    Kushel M
    JAMA Intern Med; 2014 Aug; 174(8):1377-8. PubMed ID: 24978013
    [No Abstract]   [Full Text] [Related]  

  • 10. Methadone Medical Maintenance: An Early 21st-Century Perspective.
    Novick DM; Salsitz EA; Joseph H; Kreek MJ
    J Addict Dis; 2015; 34(2-3):226-37. PubMed ID: 26110221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone in the treatment of opioid-dependent pregnant women: common ground.
    Jones HE; Chisolm MS; Jansson LM; Terplan M
    Addiction; 2013 Feb; 108(2):255-6. PubMed ID: 23331881
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of nerve growth factor and vascular endothelial growth factor A with psychometric measurements of opiate dependence: results of a pilot study in patients participating in a structured diamorphine maintenance program.
    Heberlein A; Dürsteler-MacFarland KM; Frieling H; Gröschl M; Lenz B; Bönsch D; Kornhuber J; Wiesbeck GA; Bleich S; Hillemacher T
    Eur Addict Res; 2012; 18(5):213-9. PubMed ID: 22517242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow-release oral morphine as maintenance therapy for opioid dependence.
    Ferri M; Minozzi S; Bo A; Amato L
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009879. PubMed ID: 23740540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate addiction in China: current situation and treatments.
    Tang YL; Zhao D; Zhao C; Cubells JF
    Addiction; 2006 May; 101(5):657-65. PubMed ID: 16669899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heroin addiction].
    Hosztafi S
    Acta Pharm Hung; 2011; 81(4):173-83. PubMed ID: 22329304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Craving and illicit heroin use among patients in heroin-assisted treatment.
    Blanken P; Hendriks VM; Koeter MW; van Ree JM; van den Brink W
    Drug Alcohol Depend; 2012 Jan; 120(1-3):74-80. PubMed ID: 21782351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.
    McKeganey N; Russell C; Cockayne L
    J Subst Abuse Treat; 2013 Jan; 44(1):97-102. PubMed ID: 22703715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of opioid maintenance treatment in prison settings: a systematic review.
    Hedrich D; Alves P; Farrell M; Stöver H; Møller L; Mayet S
    Addiction; 2012 Mar; 107(3):501-17. PubMed ID: 21955033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.